<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39401194</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2767-3375</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PLOS global public health</Title><ISOAbbreviation>PLOS Glob Public Health</ISOAbbreviation></Journal><ArticleTitle>Factors associated with COVID-19 vaccine hesitancy and uptake among populations in the West department of Haiti.</ArticleTitle><Pagination><StartPage>e0002864</StartPage><MedlinePgn>e0002864</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0002864</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgph.0002864</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The COVID-19 pandemic in Haiti led to increased challenges for a population concurrently dealing with natural and social disasters, poor quality health care, lack of clean running water, and inadequate housing. In 2022, the population of Haiti was 11.4 million. While half a million vaccines for COVID-19 were donated by the United States to the government of Haiti, less than 5% of the population agreed to be vaccinated. This resulted in thousands of unused doses that were diverted to other countries. The purpose of this study was to evaluate population characteristics related to vaccine uptake in order to inform future interventions to improve COVID-19 vaccine uptake as well as inform strategies to safeguard against future global health security threats.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a mixed-methods, cross-sectional study conducted in the West Department of Haiti within peri-urban communes. Participants consisted of adults in this setting responding to a survey from June 15 to July 18, 2022. The survey assessed demographic information, household characteristics, religious beliefs, past vaccine use, and current COVID-19 vaccine status. Multivariate regression modeling was conducted to assess predictors of vaccine hesitancy. Qualitative focus group discussion participants were recruited and focus group discussions were conducted between August-September 2022 among community groups, religious leaders and health professionals to provide additional, community-level context on perceptions of the COVID-19 pandemic and vaccines.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1,923 respondents completed the survey; of which a majority were male (52.7%), between the age of 18-35 (58.5%), had a medical visit within the last year (63.0%) and received the COVID-19 vaccine (46.1%). Compared to those who had been COVID-19 vaccinated, participants who had not been vaccinated were more likely to be male (57.7% vs 46.8%, p &lt; .0001), have completed secondary education (30.5% vs 16.6%, p &lt; .001), unemployed (20.3% vs 7.3%, p &lt; .0001) and had a medical visit 3 or more years ago (30.2% vs 11.2%, p &lt; .0001). Unvaccinated COVID-19 participants were also more likely to have never received any other vaccine (36.1% vs22.5%, p &lt; .0001), have a religious leader speak out against the vaccine (20.0% vs 13.1%, p &lt; .0001), not believe in the effectiveness of the vaccine (51.2% vs 9.1%, p &lt; .0001) and did not trust the healthcare worker administering the vaccine (35.2% vs 3.8%, p&lt;0.0001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results show that targeted interventions to religious leaders and health care workers on how to engage with the community and share clearer messages around the COVID-19 vaccination may result in increased vaccine uptake. Results also shed light on how activities surrounding vaccinations can be tailored to meet client needs addressing the misinformation encountered to achieve greater health impact thereby safeguarding the population against future global health security threats.</AbstractText><CopyrightInformation>Copyright: © 2024 Etienne-Mesubi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Etienne-Mesubi</LastName><ForeName>Martine</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0000-4645-7864</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oni</LastName><ForeName>Babatunji</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labbe-Coq</LastName><ForeName>Nancy Rachel</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcide-Jean-Pierre</LastName><ForeName>Marie Colette</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamarre</LastName><ForeName>Delva</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorestan</LastName><ForeName>Darwin</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0005-0768-3849</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bien-Aime</LastName><ForeName>Marie-Ange</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorce</LastName><ForeName>Venice</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freivald</LastName><ForeName>Cory</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angell</LastName><ForeName>Cowan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yingjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opoku</LastName><ForeName>Jenevieve</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazira</LastName><ForeName>Deus</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6459-5555</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice &amp; Impact, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLOS Glob Public Health</MedlineTA><NlmUniqueID>9918283779606676</NlmUniqueID><ISSNLinking>2767-3375</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39401194</ArticleId><ArticleId IdType="pmc">PMC11472929</ArticleId><ArticleId IdType="doi">10.1371/journal.pgph.0002864</ArticleId><ArticleId IdType="pii">PGPH-D-23-02641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper S, Schmidt BM, Sambala EZ, Swartz A, Colvin CJ, Leon N, et al.. Factors that influence parents’ and informal caregivers’ views and practices regarding routine childhood vaccination: a qualitative evidence synthesis. Cochrane Database of Systematic Reviews. 2021. Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013265.pub2</ArticleId><ArticleId IdType="pmc">PMC8550333</ArticleId><ArticleId IdType="pubmed">34706066</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Human Vaccines &amp; Immunotherapeutics. 2013. Aug;9(8):1763–73. doi: 10.4161/hv.24657</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24657</ArticleId><ArticleId IdType="pmc">PMC3906279</ArticleId><ArticleId IdType="pubmed">23584253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato APS. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil? Rev Saude Publica. 2018. Nov 29;52:96. doi: 10.11606/S1518-8787.2018052001199</Citation><ArticleIdList><ArticleId IdType="doi">10.11606/S1518-8787.2018052001199</ArticleId><ArticleId IdType="pmc">PMC6284490</ArticleId><ArticleId IdType="pubmed">30517523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CW, de Jong EP, Faure JA, Ellington JL, Chen CS, Chan CC. A matter of trust: a qualitative comparison of the determinants of COVID-19 vaccine hesitancy in Taiwan, the United States, the Netherlands, and Haiti. Hum Vaccin Immunother. 2022. Nov 30;18(5):2050121. doi: 10.1080/21645515.2022.2050121</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2050121</ArticleId><ArticleId IdType="pmc">PMC9225662</ArticleId><ArticleId IdType="pubmed">35349382</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015. Aug 14;33(34):4161–4. doi: 10.1016/j.vaccine.2015.04.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015. Feb 25;7:ecurrents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289. doi: 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289</ArticleId><ArticleId IdType="pmc">PMC4353679</ArticleId><ArticleId IdType="pubmed">25789201</ArticleId></ArticleIdList></Reference><Reference><Citation>National Vaccine Advisory Committee. NVAC Statement of Support Regarding Efforts to Better Implement IIS-to-IIS Data Exchange Across Jurisdictions: Approved by the National Vaccine Advisory Committee on February 10, 2015. Public Health Rep. 2015. Jul-Aug;130(4):332–5. doi: 10.1177/003335491513000409</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003335491513000409</ArticleId><ArticleId IdType="pmc">PMC4547572</ArticleId><ArticleId IdType="pubmed">26346664</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster M, Eskola J, Duclos P; SAGE Working Group on Vaccine Hesitancy. Review of vaccine hesitancy: Rationale, remit and methods. Vaccine. 2015. Aug 14;33(34):4157–60. doi: 10.1016/j.vaccine.2015.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.035</ArticleId><ArticleId IdType="pubmed">25896380</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Ten threats to global health in 2019.
World Health Organization. [cited 2022 Nov 11]. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.</Citation></Reference><Reference><Citation>Tohme RA, Francois J, Cavallaro KF, Paluku G, Yalcouye I, Jackson E, et al.. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010–2016. Am J Trop Med Hyg. 2017. Oct;97(4_Suppl):28–36. doi: 10.4269/ajtmh.16-0802</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.16-0802</ArticleId><ArticleId IdType="pmc">PMC5676636</ArticleId><ArticleId IdType="pubmed">29064356</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwell K., Freeman M. I Immunise: An evaluation of a values-based campaign to change attitudes and beliefs. Vaccine. 2014. Nov 17;33(46):6235–40. doi: 10.1016/j.vaccine.2015.09.092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.09.092</ArticleId><ArticleId IdType="pubmed">26458802</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LH, Joshi AD, Drew DA, Merino J, Ma W, Lo CH,et al.. Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom. Nat Commun. 2022. Feb 1;13(1):636. doi: 10.1038/s41467-022-28200-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28200-3</ArticleId><ArticleId IdType="pmc">PMC8807721</ArticleId><ArticleId IdType="pubmed">35105869</ArticleId></ArticleIdList></Reference><Reference><Citation>UNICEF. 2023 United Nations Children’s Fund, The State of the World’s Children 2023: For every child, vaccination, UNICEF Innocenti–Global Office of Research and Foresight, Florence, April
2023. [cited 2023 Dec 1].Available from https://www.vaccineconfidence.org/our-work/reports/the-state-of-the-worlds-children-2023/#:~:text=The%202023%20edition%20is%20the,%2C%202018%2C%202019%20and%202022.</Citation></Reference><Reference><Citation>Caribbean Public Health Agency (CARPHA). COVID-19 Situation Report No. 254. 2022 Nov 8 [cited 1 Dec 2023]. Available from https://carpha.org/What-We-Do/Public-Health/Novel-Coronavirus/CARPHA-Situation-Reports-for-COVID-19.</Citation></Reference><Reference><Citation>Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al.. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021. Jun 3;17(6):1612–1621. doi: 10.1080/21645515.2020.1846397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1846397</ArticleId><ArticleId IdType="pmc">PMC8115754</ArticleId><ArticleId IdType="pubmed">33242386</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015. Aug 14;33(34):4161–4. doi: 10.1016/j.vaccine.2015.04.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubetkin EI, Zabor EC, Isaac K, Brennessel D, Kemeny MM, Hay JL. Health literacy, information seeking, and trust in information in Haitians. Am J Health Behav. 2015. May;39(3):441–50. doi: 10.5993/AJHB.39.3.16</Citation><ArticleIdList><ArticleId IdType="doi">10.5993/AJHB.39.3.16</ArticleId><ArticleId IdType="pmc">PMC4496799</ArticleId><ArticleId IdType="pubmed">25741688</ArticleId></ArticleIdList></Reference><Reference><Citation>Musoke D, Boynton P, Butler C, Musoke MB. Health seeking behaviour and challenges in utilising health facilities in Wakiso district, Uganda. Afr Health Sci. 2014. Dec;14(4):1046–55. doi: 10.4314/ahs.v14i4.36</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v14i4.36</ArticleId><ArticleId IdType="pmc">PMC4370086</ArticleId><ArticleId IdType="pubmed">25834516</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022. Sep;22(9):1293–1302. doi: 10.1016/S1473-3099(22)00320-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00320-6</ArticleId><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al.. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021. Aug;27(8):1385–1394. doi: 10.1038/s41591-021-01454-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01454-y</ArticleId><ArticleId IdType="pmc">PMC8363502</ArticleId><ArticleId IdType="pubmed">34272499</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis TP Jr, Yimam AK, Kalam MA, Tolossa AD, Kanwagi R, Bauler S, et al., Behavioural Determinants of COVID-19-Vaccine Acceptance in Rural Areas of Six Lower- and Middle-Income Countries. Vaccines (Basel). 2022. Jan 29;10(2):214. doi: 10.3390/vaccines10020214</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020214</ArticleId><ArticleId IdType="pmc">PMC8875839</ArticleId><ArticleId IdType="pubmed">35214672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chukwuocha UM, Emerole CO, Iwuoha GN, Dozie UW, Njoku PU, Akanazu CO, et al.,. Stakeholders’ hopes and concerns about the COVID-19 vaccines in Southeastern Nigeria: a qualitative study. BMC Public Health. 2022. Feb 16;22(1):330. doi: 10.1186/s12889-022-12754-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-12754-4</ArticleId><ArticleId IdType="pmc">PMC8848682</ArticleId><ArticleId IdType="pubmed">35172789</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinga JN, Sinda LK, Titanji VPK. Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication. Vaccines (Basel). 2021. Feb 19;9(2):175. doi: 10.3390/vaccines9020175</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020175</ArticleId><ArticleId IdType="pmc">PMC7922050</ArticleId><ArticleId IdType="pubmed">33669659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al.. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021. Mar 13;397(10278):1023–1034. doi: 10.1016/S0140-6736(21)00306-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00306-8</ArticleId><ArticleId IdType="pmc">PMC7906643</ArticleId><ArticleId IdType="pubmed">33587887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan American Health Organization (PAHO).
COVID-19: Increasing Vaccination Coverage in Haiti through community outreach. 2022. 
September [cited 2023 Dec 1] Available from https://www.paho.org/en/stories/covid-19-increasing-vaccination-coverage-haiti-through-community-outreach.</Citation></Reference><Reference><Citation>Burger MN, Mayer M, Steimanis I. Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany. PLoS One. 2022. Jun 28;17(6):e0270666. doi: 10.1371/journal.pone.0270666</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270666</ArticleId><ArticleId IdType="pmc">PMC9239477</ArticleId><ArticleId IdType="pubmed">35763537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen UT, Ayers S, Koskan AM. Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions. PLoS One. 2022. Apr 6;17(4):e0265736. doi: 10.1371/journal.pone.0265736</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265736</ArticleId><ArticleId IdType="pmc">PMC8985948</ArticleId><ArticleId IdType="pubmed">35385505</ArticleId></ArticleIdList></Reference><Reference><Citation>Price R, Cho J, Nelson S. SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti. Cureus. 2022. Aug 4;14(8):e27690. doi: 10.7759/cureus.27690</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.27690</ArticleId><ArticleId IdType="pmc">PMC9440879</ArticleId><ArticleId IdType="pubmed">36072217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>